University Hospital, Akershus
Clinical trials sponsored by University Hospital, Akershus, explained in plain language.
-
Simple blood test may save lives of hospital patients with fast breathing
Disease control OngoingThis study looks at whether measuring certain blood markers early and giving structured feedback to doctors can help patients hospitalized with rapid breathing (tachypnea). About 574 adults will be randomly assigned to either receive this early testing or standard care. The goal …
Phase: NA • Sponsor: University Hospital, Akershus • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Kids with IBD may get their infusion time cut in half without extra risk
Symptom relief OngoingThis study looks at whether giving infliximab over 30 minutes is as safe as the usual 60-minute infusion for children with inflammatory bowel disease (IBD). About 60 children aged 1 to 17 who have already had at least 5 infliximab infusions will receive 8 infusions, alternating b…
Phase: NA • Sponsor: University Hospital, Akershus • Aim: Symptom relief
Last updated May 01, 2026 21:57 UTC
-
Heart monitors after mystery strokes: a lifesaver for women?
Knowledge-focused OngoingThis study follows 1400 women who had a stroke with no known cause. It tests if using a small heart monitor for a long time can find hidden heart rhythm problems (atrial fibrillation) and if treating those with blood thinners reduces the chance of another stroke. The goal is to s…
Sponsor: University Hospital, Akershus • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC
-
Breathing gas levels may impact brain health during prostate surgery
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how different carbon dioxide levels in the blood affect brain blood flow and thinking after robot-assisted prostate surgery. About 46 men aged 55-80 will be randomly assigned to receive high or low carbon dioxide during anesthesia. Researchers will measure bra…
Phase: NA • Sponsor: University Hospital, Akershus • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC
-
Major study launches to uncover heart risks of hormone therapy for transgender individuals
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 450 people with gender incongruence who are starting or continuing gender-affirming hormone therapy. Researchers will use heart scans, blood tests, and quality-of-life surveys over several years to see if the therapy changes heart structure or raises cardiovasc…
Sponsor: University Hospital, Akershus • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC